The Roots Analysis team is putting in its best effort to offer our clients / readers a reliable source of information, regarding how the pharmaceutical and biotech sectors are coping in the midst of the COVID-19 pandemic. Our intention is to generate realistic insights, based on a variety of factors, which are anticipated to influence both prevalent and future market dynamics. Reach out to us for any help.

Telemedicine Tools and Software Providers Market: Focus on Remote Patient Monitoring, Distribution by Area of Application (Blood Glucose, Blood Pressure, Oxygen Saturation, and Others), Therapeutic Areas (Cardiovascular Disorders, Infectious Diseases, Metabolic Disorders, and Others), Product / Software Purpose (Commercial and Clinical Purpose), Type of Business Model, and Geography (North America, Europe, Asia-Pacific, Latin America, and MENA): Industry Trends and Global Forecasts, 2021-2030

  • Lowest Price Guaranteed From USD 5,899

  • Published
    September 2021

  • Pages
    190

  • View Count
    1783

Example Insights

Telemedicine-Tools-and-Software-Providers-Market-Context Telemedicine-Tools-and-Software-Providers-Market-List-Of-Developer Telemedicine-Tools-and-Software-Providers-Market-Distribution-by-Status-of-Development
Telemedicine-Tools-and-Software-Providers-Market-Product-Competitiveness-Analysis Telemedicine-Tools-and-Software-Providers-Market-Partnerships-and-Collaborations Telemedicine-Tools-and-Software-Providers-Market-Funding-and-Investments
Telemedicine-Tools-and-Software-Providers-Market-Likely-Scenarios Telemedicine-Tools-and-Software-Providers-Market-Opportunity  

 

Overview

In the last few years, there has been an evident rise in the global disease burden. More importantly, the inability to report a health issue to a medical practitioner in its initial stages is expected to cost over USD 90 billion in excess and more than USD 40 billion in productivity loss, each year. Moreover, a number of individuals that are required to frequent hospitals for monitoring of their health conditions, such visits cause additional financial burden. The aforementioned concerns can be mitigated by shifting to a home-based care setting. Amidst the recent initiatives in this context, remote patient monitoring (RPM) has emerged as a potent and sought-after alternative in the healthcare industry. During the COVID-19 pandemic, the healthcare industry evolved significantly, due to the need and urgency to treat patients with the aid of telemedicine and digital platforms. Remote Patient Monitoring (RPM) technologies enable monitoring of patients virtually for a wide range of diseases from anywhere around the globe. It is worth mentioning that large volumes of health data can be accessed by medical researchers on dedicated cloud servers that have been designed to comply with the Health Insurance Portability and Accountability Act (HIPAA) of 1996. In addition to improved quality of care and better access to the patients, remote patient monitoring (RPM) offers ease of implementation, leading to substantial time and cost saving (by eliminating the need for transportation and waiting in queue to meet the physician).

Considering the various advantages offered by remote patient monitoring (RPM), healthcare organizations are gradually becoming more receptive to adopting such software solutions for their regular use. As a matter of fact, the recent surge in demand for remote monitoring amidst the COVID-19 pandemic has served to create a strong case for organizations to shift to the use of remote patient monitoring consultation tools and software. In fact, a recent study stated that over 50% of the healthcare consumers would consider using remote patient monitoring (RPM) solutions as a part of their medical treatment, if recommended by their physician. Over the years, telemedicine start-ups have seen a significant growth. These companies are engaged in providing tailored solutions, along with remote access of medical care facilities to the patients. It is worth mentioning that around 90% of the healthcare organizations have either invested or intend to invest in remote patient monitoring systems. Given the rising trend of remote patient monitoring software solutions in the healthcare industry and the ongoing efforts of software providers to further improve / expand their respective offerings, we believe that the remote patient monitoring consultation tools and software providers market is likely to evolve at a steady pace, till 2030.

Scope of the Report

The “Telemedicine Tools and Software Providers Market: Focus on Remote Patient Monitoring, 2021-2030, Distribution by Area of  Application (Blood Glucose, Blood Pressure, Body Temperature, Electrocardiogram, Oxygen Saturation, Respiration Rate, and Others), Therapeutic Areas (Cardiovascular Disorders, Infectious Diseases, Metabolic Disorders, Oncological Disorders, Respiratory Disorder, and Others), Product / Software Purpose (Commercial Purpose and Clinical Purpose), Type of Business Model (B2B and B2C), and Geography (North America, Europe, Asia-Pacific, Latin America, and MENA)” report features an extensive study of the current market landscape and the likely future potential of the remote patient monitoring software providers market, over the next decade. The study also features an in-depth analysis, highlighting the capabilities of various industry stakeholders engaged in this field. Amongst other elements, the report features:

  • A detailed overview of the overall market landscape of players engaged in providing remote patient monitoring consultation tools and software, along with the information on several relevant parameters, such as year of establishment, company size, location of headquarters. Further, it highlights a detailed assessment of the overall market landscape of more than 200 consultation tools and software based on several relevant parameters, such as type of software (software as a system and software as a service), area of  application (blood glucose, blood pressure, electrocardiogram (ECG), oxygen saturation, respiration rate, temperature, and others), therapeutic areas (cardiovascular disorders, infectious diseases, metabolic disorders, oncological disorders, respiratory disorder, and other disorders), product / software purpose (commercial purpose and clinical study purpose), type of telemedicine operation (store-and-forward, remote monitoring, and real-time), type of remote patient monitoring service (data collection, transmission, evaluation, and notification), type of business model (B2B and B2C). 
  • Elaborate profiles of prominent players (shortlisted based on number of software being offered by mid-sized and large players established before 2010) engaged in the development of remote patient monitoring software. Each company profile features a brief overview of the company, along with information on year of establishment, number of employees, location of headquarters, key executives, financial details / information (if available), product portfolio, recent developments and an informed future outlook.
  • An analysis of the recent partnerships inked between remote patient monitoring software providers, during the period 2015-2021 Additionally, it includes a brief description of the various types of partnerships models (such as product / software integration agreement, service alliance, service agreement, product / software development agreement, full business acquisition, product / software distribution agreement, product / software utlilization agreement, and product portfolio acquisition) that have been adopted by stakeholders engaged in this domain, during the period 2015-2021.
  • A detailed analysis of various investments made by players engaged in this domain based on several relevant parameters, such as year of investment, number of funding instances, amount invested and type of funding (such as, venture capital, private equity, secondary offerings, debt, initial public offering (IPO), other equity, seed, grant, and others), along with information on the most active players (in terms of number of funding instances and amount raised) and most active investors (in terms of number of funding instances).
  • An in-depth product competitiveness analysis of remote patient monitoring software based on supplier power (in terms of expertise of the developer) and key product-related specifications (such as status of development, HIPPA compliant, type of software, area(s) of application, number of therapeutic areas, purpose of software, number of patient monitoring related services, type of telemedicine operation, and type of business model).
  • An insightful analysis highlighting the likely cost saving potential associated with the use of remote patient monitoring consultation tools and software solutions, taking into consideration various parameters, such as number of patient visits (in-patient and out-patient) and increase in efficiency by adoption of remote patient monitoring software solutions.
  • An elaborate discussion on how the recent COVID-19 pandemic is likely to impact the remote patient monitoring software market, along with information on the key initiatives undertaken by players engaged in this domain to overcome the challenges faced due to the pandemic.
  • A discussion on affiliated trends, key drivers and challenges, under a SWOT framework, which are likely to impact the industry’s evolution, along with a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall remote patient monitoring tools and software providers industry.

One of the key objectives of this report was to evaluate the current opportunity and the future potential associated with the remote patient monitoring consultation tools and software providers market, over the coming decade. We have developed an informed estimate on the likely evolution of the market in the short to mid-term and long term, for the period 2021-2030. Additionally, the report features the likely distribution of the current and forecasted opportunity across [A] area of  application (blood glucose, blood pressure, ECG, oxygen saturation, respiration rate, temperature, and others) [B] target therapeutic area (cardiovascular disorders, infectious diseases, metabolic disorders, oncological disorders, respiratory disorder, and others), [C] software purpose (commercial purpose and clinical study purpose), [D] type of business model (B2B and B2C), and [E] key geographical regions (North America, Europe, Asia-Pacific, Latin America, and MENA (Middle East and North Africa)). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Key Questions Answered

  • Who are the leading players engaged in the development of remote patient monitoring tools and software?
  • Which type of software is most commonly offered by remote patient monitoring consultation tools and software providers?
  • Which kind of partnership models are commonly adopted by stakeholders engaged in this industry?
  • What is the relative competitiveness of different remote patient monitoring software solutions?
  • What is the likely cost saving potential associated with the use of remote patient monitoring software?
  • What are the key challenges currently faced by stakeholders in this industry?
  • What are the anticipated future trends related to remote patient monitoring consultation tools and software providers?
  • How is the current and future market opportunity likely to be distributed across key market segments? 
  • What is the likely impact of the ongoing COVID-19 pandemic on the overall remote patient monitoring market?

Contents

Chapter Outlines

Chapter 2 is an executive summary of key insights captured in our research. It offers a high-level view on the current state of remote patient monitoring market and its likely evolution in the mid to long term. 
 
Chapter 3 provides a general introduction to remote patient monitoring tools and software, featuring details related to the current and future trends in the domain. It further includes a brief introduction to the concept of telemedicine and its types, along with information on the need for software systems in this domain, along with the various patient monitoring related services offered by players. Furthermore, it highlights prevalent regulatory guidelines, as well as advantages and risks associated with the use of such tools and software. 
 
Chapter 4 provides a detailed review of the overall market landscape of players engaged in providing remote patient monitoring consultation tools and software, along with the information on several relevant parameters, such as year of establishment, company size, location of headquarters. Further, it highlights a detailed assessment of the overall market landscape of more than 200 consultation tools and software based on several relevant parameters, such as type of software (software as a system and software as a service), area of  application (blood glucose, blood pressure, electrocardiogram (ECG), oxygen saturation, respiration rate, temperature, and others), therapeutic areas (cardiovascular disorders, infectious diseases, metabolic disorders, oncological disorders, respiratory disorder, and other disorders), product / software purpose (commercial purpose and clinical study purpose), type of telemedicine operation (store-and-forward, remote monitoring, and real-time), type of remote patient monitoring service (data collection, transmission, evaluation, and notification), type of business model (B2B and B2C).  

Chapter 5 features elaborate profiles of prominent players (shortlisted based on number of software being offered by mid-sized and large players established before 2010) engaged in the development of remote patient monitoring software. Each company profile features a brief overview of the company, along with information on its year of establishment, number of employees, location of headquarters, key executives, financial details / information (if available), product portfolio, recent developments and an informed future outlook.

Chapter 6 features an analysis of the recent partnerships inked between remote patient monitoring software providers, during the period 2015-2021 Additionally, it includes a brief description of the various types of partnerships models (such as product / software integration agreement, service alliance, service agreement, product / software development agreement, full business acquisition, product / software distribution agreement, product / software utlilization agreement, and product portfolio acquisition) that have been adopted by stakeholders engaged in this domain, during the period 2015-2021.

Chapter 7 provides an analysis of various investments made by players engaged in this domain based on several relevant parameters, such as year of investment, number of funding instances, amount invested and type of funding (such as, venture capital, private equity, secondary offerings, debt, initial public offering (IPO), other equity, seed, grant, and others), along with information on the most active players (in terms of number of funding instances and amount raised) and most active investors (in terms of number of funding instances).

Chapter 8 features an in-depth product competitiveness analysis of remote patient monitoring software based on supplier power (in terms of expertise of the developer) and key product-related specifications (such as status of development, HIPPA compliant, type of software, area(s) of application, number of therapeutic areas, purpose of software, number of patient monitoring related services, type of telemedicine operation, and type of business model).

Chapter 9 presents insights from an insightful analysis highlighting the likely cost saving potential associated with the use of remote patient monitoring consultation tools and software solutions, taking into consideration various parameters, such as number of patient visits (in-patient and out-patient) and increase in efficiency by adoption of remote patient monitoring software solutions.

Chapter 10 features a detailed market forecast analysis, highlighting the likely evolution of the market in the short to mid-term and long term, for the period 2021-2030. Additionally, the report features the likely distribution of the current and forecasted opportunity across [A] area of  application (blood glucose, blood pressure, ECG, oxygen saturation, respiration rate, temperature, and others) [B] target therapeutic area (cardiovascular disorders, infectious diseases, metabolic disorders, oncological disorders, respiratory disorder, and others), [C] software purpose (commercial purpose and clinical study purpose), [D] type of business model (B2B and B2C), and [E] key geographical regions (North America, Europe, Asia-Pacific, Latin America, and MENA (Middle East and North Africa)). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.

Chapter 11 features an insightful discussion on how the recent COVID-19 pandemic is likely to impact the remote patient monitoring software market, along with information on the key initiatives undertaken by the developers engaged in this domain to overcome the challenges faced due to the pandemic.

Chapter 12 provides a detailed discussion on affiliated trends, key drivers and challenges, under a SWOT framework, which are likely to impact the industry’s evolution, along with a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall remote patient monitoring tools and software providers industry.

Chapter 13 is a summary of the entire report. In this chapter, we have provided a list of key takeaways from the report, and expressed our independent opinion related to the research and analysis described in the previous chapters.

Chapter 14 is a collection of interview transcripts of the discussion(s) that were held key stakeholders in the industry. 

Chapter 15 is an appendix, which provides tabulated data and numbers for all the figures included in the report.

Chapter 16 is an appendix, which contains a list of companies and organizations mentioned in this report.

Table Of Contents

 1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION 
3.1. Chapter Overview
3.2. Introduction to Telemedicine
3.2.1. Store-and-Forward Telemedicine
3.2.2. Real-Time Telemedicine
3.2.3. Telemedicine in Remote Patient Monitoring  
3.3. Advantages of Remote Patient Monitoring
3.4. Limitations Associated with Remote Patient Monitoring
3.5. Regulatory Considerations for Remote Patient Monitoring Solutions
3.6. Concluding Remarks

4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Remote Patient Monitoring Consultation Tools and Software: Overall Market Landscape
4.2.1. Analysis by Type of Software
4.2.2. Analysis by Purpose of Software
4.2.3. Analysis by Area of Application
4.2.4. Analysis by Therapeutic Area
4.2.5. Analysis by Type of Telemedicine Operation
4.2.6. Analysis by Type of Remote Patient Monitoring Service Offered
4.2.7. Analysis by Type of Business Model

4.3. Remote Patient Monitoring Consultation Tools and Software: Solution Providers Landscape
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters

5. COMPANY PROFILES
5.1. Chapter Overview 
5.2. Players based in North America
5.2.1. BioTelemetry
5.2.1.1. Company Overview
5.2.1.2. Financial Information
5.2.1.3. Software Portfolio
5.2.1.4. Future Outlook

5.2.2. LeewayHertz
5.2.2.1. Company Overview
5.2.2.2. Software Portfolio
5.2.2.3. Future Outlook

5.2.3. Masimo
5.2.3.1. Company Overview
5.2.3.2. Financial Information
5.2.3.3. Software Portfolio
5.2.3.4. Future Outlook

5.3. Players based in Europe
5.3.1. Braster
5.3.1.1. Company Overview
5.3.1.2. Software Portfolio
5.3.1.3. Future Outlook

5.3.2. LifeWatch
5.3.2.1. Company Overview
5.3.2.2. Software Portfolio
5.3.2.3. Future Outlook

5.3.3. Medtronic
5.3.3.1. Company Overview
5.3.3.2. Financial Information
5.3.3.3. Software Portfolio
5.3.3.4. Future Outlook

5.3.4. Siemens Healthineers
5.3.4.1. Company Overview
5.3.4.2. Financial Information
5.3.4.3. Software Portfolio
5.3.4.4. Future Outlook

5.4. Players based in Asia-Pacific
5.4.1. Transtek Medical
5.4.1.1. Company Overview
5.4.1.2. Financial Information
5.4.1.3. Software Portfolio
5.4.1.4. Future Outlook

6. PARTNERSHIPS AND COLLABORATIONS
6.1. Chapter Overview
6.2. Partnership Models

6.3. Remote Patient Monitoring Consultation Tools and Software Providers: Recent Partnerships and Collaborations
6.3.1. Analysis by Year of Partnership
6.3.2. Analysis by Type of Partnership
6.3.2.1. Analysis by Year and Type of Partnership
6.3.2.2. Analysis by Type of Partnership and Company Size

6.3.3. Analysis by Type of Software
6.3.3.1. Analysis by Year of Partnership and Type of Software
6.3.3.2. Analysis by Type of Partnership and Type of Software

6.3.4. Most Active Players: Analysis by Number of Partnerships
6.3.5. Regional Analysis
6.3.5.1. Intercontinental and Intracontinental Agreements

7. FUNDING AND INVESTMENT ANALYSIS
7.1. Chapter Overview
7.2. Types of Funding

7.3. Remote Patient Monitoring Consultation Tools and Software Providers: Funding and Investment Analysis
7.3.1. Analysis by Cumulative Year-wise Trend, 2015 - 2021
7.3.2. Analysis by Amount Invested
7.3.3. Analysis by Type of Funding
7.3.3.1. Analysis by Type of Venture Capital Round
7.3.4. Analysis by Type of Software
7.3.5. Analysis by Focus Area
7.3.6. Analysis by Geography
7.3.7. Most Active Players: Analysis by Number of Instances
7.3.8. Most Active Players: Analysis by Amount Invested
7.3.9. Most Active Investors: Analysis by Number of Instances
7.3.10. Analysis by Year, Amount Invested and Type of Investor

7.4. Concluding Remarks

8. PRODUCT COMPETITIVENESS ANALYSIS
8.1. Chapter Overview
8.2. Methodology 
8.3. Assumptions / Key Parameters
8.4. Product Competitiveness: Software as a Service
8.5. Product Competitiveness: Software as a System

9. COST SAVING ANALYSIS
9.1. Chapter Overview
9.2. Key Assumptions and Methodology

9.3. Remote Patient Monitoring Solutions: Overall Cost Saving Potential 
9.3.1. Likely Cost Savings in North America, 2021-2030
9.3.2. Likely Cost Savings in Europe, 2021-2030
9.3.3. Likely Cost Savings in Asia, 2021-2030
9.3.4. Likely Cost Savings in Rest of the World, 2021-2030

9.4. Conclusion

10. MARKET FORECAST
10.1. Chapter Overview
10.2. Forecast Methodology and Key Assumptions
10.3. Global Remote Patient Monitoring Consultation Tools and Software Providers Market, 2021-2030
10.4. Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Type of Area of Application
10.4.1. Remote Patient Monitoring Consultation Tools and Software Providers Market for Blood Glucose, 2021-2030
10.4.2. Remote Patient Monitoring Consultation Tools and Software Providers Market for Blood Pressure, 2021-2030
10.4.3. Remote Patient Monitoring Consultation Tools and Software Providers Market for ECG, 2021-2030
10.4.4. Remote Patient Monitoring Consultation Tools and Software Providers Market for Oxygen Saturation, 2021-2030
10.4.5. Remote Patient Monitoring Consultation Tools and Software Providers Market for Respiration Rate, 2021-2030
10.4.6. Remote Patient Monitoring Consultation Tools and Software Providers Market for Body Temperature, 2021-2030
10.4.7. Remote Patient Monitoring Consultation Tools and Software Providers Market for Other Areas of Application, 2021-2030

10.5. Global Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Therapeutic Area
10.5.1. Remote Patient Monitoring Consultation Tools and Software Providers Market for Cardiovascular Disorders, 2021-2030
10.5.2. Remote Patient Monitoring Consultation Tools and Software Providers Market for Infectious Diseases, 2021-2030
10.5.3. Remote Patient Monitoring Consultation Tools and Software Providers Market for Metabolic Disorders, 2021-2030
10.5.4. Remote Patient Monitoring Consultation Tools and Software Providers Market for Oncological Disorders, 2021-2030
10.5.5. Remote Patient Monitoring Consultation Tools and Software Providers Market for Respiratory Disorders, 2021-2030
10.5.6. Remote Patient Monitoring Consultation Tools and Software Providers Market for Other Therapeutic Areas, 2021-2030

10.6. Global Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Purpose of Software
10.6.1. Remote Patient Monitoring Consultation Tools and Software Providers Market for Clinical Studies, 2021-2030
10.6.2. Remote Patient Monitoring Consultation Tools and Software Providers Market for Commercial Purposes, 2021-2030

10.7. Global Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Type of Business Model
10.7.1. Remote Patient Monitoring Consultation Tools and Software Providers Market for B2B, 2021-2030
10.7.2. Remote Patient Monitoring Consultation Tools and Software Providers Market for B2C, 2021-2030

10.8. Global Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Geography
10.8.1. Remote Patient Monitoring Consultation Tools and Software Providers Market in North America, 2021-2030
10.8.2. Remote Patient Monitoring Consultation Tools and Software Providers Market in Europe, 2021-2030
10.8.3. Remote Patient Monitoring Consultation Tools and Software Providers Market in Asia-Pacific, 2021-2030
10.8.4. Remote Patient Monitoring Consultation Tools and Software Providers Market in Middle-East and North Africa (MENA), 2021-2030
10.8.5. Remote Patient Monitoring Consultation Tools and Software Providers Market in Latin America, 2021-2030

11. IMPACT OF COVID-19 PANDEMIC ON DIGITAL SOLUTIONS FOR BIOMARKERS MARKET
11.1. Chapter Overview
11.2. Impact of COVID-19 on Telemedicine and Remote Patient Monitoring
11.2.1. Impact on Future Market Opportunity for Remote Patient Monitoring
11.3. Recuperative Initiatives of Key Players

11.4. Recuperative Strategies for Businesses
11.4.1. Strategies for Implementation in the Short / Mid Term
11.4.2. Strategies for Implementation in the Long Term

12. SWOT ANALYSIS
12.1. Chapter Overview
12.2. Strengths
12.3. Weaknesses
12.4. Opportunities
12.5. Threats
12.6. Comparison of SWOT Factors

13. CONCLUSION

14. INTERVIEW TRANSCRIPTS
14.1. Chapter Overview
14.2. AltumView System
14.2.1. Company Snapshot
14.2.2. Survey Transcript: John Wu, Co-Founder

15. APPENDIX I: TABULATED DATA

16. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures 

Figure 3.1 Type of Telemedicine
Figure 3.2 Steps Involved in Remote Patient Monitoring
Figure 3.3 Key Benefits and Limitations of RPM Solutions
Figure 4.1 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Software
Figure 4.2 Remote Patient Monitoring Consultation Tools and Software: Distribution by Purpose of Software
Figure 4.3 Remote Patient Monitoring Consultation Tools and Software: Distribution by Area of Application
Figure 4.4 Remote Patient Monitoring Consultation Tools and Software: Distribution by Therapeutic Area
Figure 4.5 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Telemedicine Operation
Figure 4.6 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Remote Patient Monitoring Service Offered
Figure 4.7 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Business Model
Figure 4.8 Remote Patient Monitoring Consultation Tools and Software: Distribution by Year of Establishment
Figure 4.9 Remote Patient Monitoring Consultation Tools and Software: Distribution by Company Size
Figure 4.10 Remote Patient Monitoring Consultation Tools and Software: Distribution by Location of Headquarters
Figure 4.11 Most Active Players: Distribution by Number of Remote Patient Monitoring Solutions
Figure 4.12 Tree Map Representation: Distribution by Type of Software and Therapeutic Area
Figure 4.13 Stacked Bar Chart Representation: Distribution by Type of Software and Area of Application
Figure 5.1 BioTel Care: Annual Revenues, 2015-2021 (USD Million)
Figure 5.2 Masimo: Annual Revenues, 2015-2021 (USD Million)
Figure 5.3 Medtronic: Annual Revenues, 2015-2021 (USD Million)
Figure 5.4 Siemens Healthineers: Annual Revenues, 2015-2021 (USD Million)
Figure 5.5 Transtek Medical: Annual Revenues, 2015-2021 (USD Million)
Figure 6.1 Partnerships and Collaborations: Distribution by Year of Partnership
Figure 6.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 6.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 6.4 Partnerships and Collaborations: Distribution by Type of Partnership and Company Size
Figure 6.5 Partnerships and Collaborations: Distribution by Type of Software
Figure 6.6 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Software
Figure 6.7 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Software
Figure 6.8 Most Active Players: Distribution by Number of Partnerships
Figure 6.9 Partnerships and Collaborations: Regional Distribution
Figure 6.10 Partnerships and Collaborations: Country-wise Distribution
Figure 6.11 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 7.1 Funding and Investment Analysis: Distribution by Cumulative Year-wise Trend, 2015 - 2021
Figure 7.2 Funding and Investment Analysis: Distribution by Amount Invested (USD Million)
Figure 7.3 Funding and Investment Analysis: Distribution by Type of Funding
Figure 7.4 Funding and Investment Analysis: Distribution by Type of Venture Capital Round
Figure 7.5 Funding and Investment Analysis: Distribution by Year and Type of Funding
Figure 7.6 Funding and Investment Analysis: Distribution by Type of Funding and Amount Invested (USD Million)
Figure 7.7 Funding and Investment Analysis: Distribution by Type of Investor
Figure 7.8 Funding and Investment Analysis: Distribution by Type of Software
Figure 7.9 Funding and Investment Analysis: Distribution by Type of Software and Amount Invested (USD Million)
Figure 7.10 Funding and Investment Analysis: Distribution by Focus Area
Figure 7.11 Funding and Investment Analysis: Distribution by Geography
Figure 7.12 Funding and Investment Analysis: Distribution by Amount Invested (USD Million) and Region
Figure 7.13 Most Active Players: Distribution by Number of Instances
Figure 7.14 Most Active Players: Distribution by Amount Invested (USD Million)
Figure 7.15 Most Active Investors: Distribution by Number of Instances
Figure 7.16 Funding and Investment Analysis: Distribution by Year, Amount Invested and Type of Investor
Figure 8.1 Product Competitiveness Analysis: Software as a Service
Figure 8.2 Product Competitiveness Analysis: Software as a System
Figure 9.1 Overall Cost Saving Potential Associated with Remote Patient Monitoring Solutions, 2021-2030 (USD Million)
Figure 9.2 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in North America, 2021-2030 (USD Million)
Figure 9.3 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in Europe, 2021-2030 (USD Million)
Figure 9.4 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in Asia-Pacific, 2021-2030 (USD Million)
Figure 9.5 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in RoW, 2021-2030 (USD Million)
Figure 10.1 Global Remote Patient Monitoring Consultation Tools and Software Market, 2021-2030 (USD Million)
Figure 10.2 Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Type of Area of Application, 2021 and 2030
Figure 10.3 Remote Patient Monitoring Consultation Tools and Software Market for Blood Glucose, 2021-2030 (USD Million)
Figure 10.4 Remote Patient Monitoring Consultation Tools and Software Market for Blood Pressure, 2021-2030 (USD Million)
Figure 10.5 Remote Patient Monitoring Consultation Tools and Software Market for Blood Temperature, 2021-2030 (USD Million)
Figure 10.6 Remote Patient Monitoring Consultation Tools and Software Market for ECG, 2021-2030 (USD Million)
Figure 10.7 Remote Patient Monitoring Consultation Tools and Software Market for Oxygen Saturation, 2021-2030 (USD Million)
Figure 10.8 Remote Patient Monitoring Consultation Tools and Software Market for Respiration Rate, 2021-2030 (USD Million)
Figure 10.9 Remote Patient Monitoring Consultation Tools and Software Market for Other Areas of Application, 2021-2030 (USD Million)
Figure 10.10 Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Therapeutic Area, 2021 and 2030
Figure 10.11 Remote Patient Monitoring Consultation Tools and Software Market for Cardiovascular Disorders, 2021-2030 (USD Million)
Figure 10.12 Remote Patient Monitoring Consultation Tools and Software Market for Infectious Diseases, 2021-2030 (USD Million)
Figure 10.13 Remote Patient Monitoring Consultation Tools and Software Market for Metabolic Disorders, 2021-2030 (USD Million)
Figure 10.14 Remote Patient Monitoring Consultation Tools and Software Market for Oncological Disorders, 2021-2030 (USD Million)
Figure 10.15 Remote Patient Monitoring Consultation Tools and Software Market for Respiratory Disorders, 2021-2030 (USD Million)
Figure 10.16 Remote Patient Monitoring Consultation Tools and Software Market for Other Therapeutic Areas, 2021-2030 (USD Million)
Figure 10.17 Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Purpose of Software, 2021 and 2030
Figure 10.18 Remote Patient Monitoring Consultation Tools and Software Market for Clinical Purpose, 2021-2030 (USD Million)
Figure 10.19 Remote Patient Monitoring Consultation Tools and Software Market for Commercial Purposes, 2021-2030 (USD Million)
Figure 10.20 Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Type of Business Model, 2021 and 2030
Figure 10.21 Remote Patient Monitoring Consultation Tools and Software Market for B2B, 2021-2030 (USD Million)
Figure 10.22 Remote Patient Monitoring Consultation Tools and Software Market for B2C, 2021-2030 (USD Million)
Figure 10.23 Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Geography, 2021 and 2030
Figure 10.24 Remote Patient Monitoring Consultation Tools and Software Market in North America, 2021-2030 (USD Million)
Figure 10.25 Remote Patient Monitoring Consultation Tools and Software Market in Europe, 2021-2030 (USD Million)
Figure 10.26 Remote Patient Monitoring Consultation Tools and Software Market in Asia-Pacific, 2021-2030 (USD Million)
Figure 10.27 Remote Patient Monitoring Consultation Tools and Software Market in MENA, 2021-2030 (USD Million)
Figure 10.28 Remote Patient Monitoring Consultation Tools and Software Market in Latin America, 2021-2030 (USD Million)
Figure 11.1 Remote Patient Monitoring Market, 2021-2030: COVID-19 Impact Scenario (USD Million)
Figure 11.2 Key RPM Consultation Tools and Software Providers
Figure 12.1 Remote Patient Monitoring Consultation Tools and Software Providers: SWOT Analysis
Figure 12.2 Comparison of SWOT Factors: Harvey Ball Analysis
Figure 13.1 Concluding Remarks: Current Market Landscape
Figure 13.2 Concluding Remarks: Recent Partnerships
Figure 13.3 Concluding Remarks: Funding Analysis
Figure 13.4 Concluding Remarks: Cost Saving Analysis
Figure 13.5 Concluding Remarks: Market Sizing and Opportunity Analysis
Figure 13.6 Concluding Remarks: Market Sizing and Opportunity Analysis by Geography

List Of Tables

Table 4.1 Remote Patient Monitoring Consultation Tools and Software: Information on Status of Software Development, Approved Countries, HIPAA Compliance and Software Specification
Table 4.2 Remote Patient Monitoring Consultation Tools and Software: Information on Area of Application
Table 4.3 Remote Patient Monitoring Consultation Tools and Software: Information on Therapeutic Area
Table 4.4 Remote Patient Monitoring Consultation Tools and Software: Information on Purpose of Software and Type of Business Model
Table 4.5 Remote Patient Monitoring Consultation Tools and Software: Information on Type of Telemedicine Operation and Patient Monitoring Related Services
Table 4.6 Remote Patient Monitoring Consultation Tools and Software: Information on Year of Establishment, Company Size and Location of Headquarters
Table 5.1 BioTel Care: Company Overview
Table 5.2 BioTel Care: Software Portfolio
Table 5.3 BioTel Care: Future Outlook
Table 5.4 LeewayHertz: Company Overview
Table 5.5 LeewayHertz: Software Portfolio
Table 5.6 Masimo: Company Overview
Table 5.7 Masimo: Software Portfolio
Table 5.8 Masimo: Future Outlook
Table 5.9 Braster: Company Overview
Table 5.10 Braster: Software Portfolio
Table 5.11 LifeWatch: Company Overview
Table 5.12 LifeWatch: Software Portfolio
Table 5.13 LifeWatch: Future Outlook
Table 5.14 Medtronic: Company Overview
Table 5.15 Medtronic: Software Portfolio
Table 5.16 Medtronic: Future Outlook
Table 5.17 Siemens Healthineers: Company Overview
Table 5.18 Siemens Healthineers: Software Portfolio
Table 5.19 Siemens Healthineers: Future Outlook
Table 5.20 Transtek Medical: Company Overview
Table 5.21 Transtek Medical: Software Portfolio
Table 5.22 Transtek Medical: Future Outlook
Table 6.1 Partnerships and Collaborations: Information on Partner, Year of Partnership, Type of Partnership and Type of Software, 2015-2021
Table 7.1 Fundings and Investments: Information on Type of Funding, Year of Investment, Amount Invested and Lead Investors, 2015-2021
Table 7.2 Funding and Investment Analysis: Summary of Investments
Table 7.3 Funding and Investment Analysis: Summary of Venture Capital Round
Table 7.4 Fundings and Investments: Information on Year of Establishment, Location of Headquarters of Recipients, Software, Type of Software, and Focus Area
Table 13.1 Remote Patient Monitoring Consultation Tools and Service Providers: List of RPM Software Focused on COVID-19 Patient Monitoring
Table 13.2 Remote Patient Monitoring Consultation Tools and Service Providers: Information on Partnerships Focused on COVID-19
Table 14.1 AltumView System: Company Snapshot
Table 15.1 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Software
Table 15.2 Remote Patient Monitoring Consultation Tools and Software: Distribution by Purpose of Software
Table 15.3 Remote Patient Monitoring Consultation Tools and Software: Distribution by Area of Application
Table 15.4 Remote Patient Monitoring Consultation Tools and Software: Distribution by Therapeutic Area
Table 15.5 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Telemedicine Operation
Table 15.6 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Remote Patient Monitoring Service Offered
Table 15.7 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Business Model
Table 15.8 Remote Patient Monitoring Consultation Tools and Software: Distribution by Year of Establishment
Table 15.9 Remote Patient Monitoring Consultation Tools and Software: Distribution by Company Size
Table 15.10 Remote Patient Monitoring Consultation Tools and Software: Distribution by Location of Headquarters
Table 15.11 Most Active Players: Distribution by Number of Remote Patient Monitoring Solutions
Table 15.12 Tree Map Representation: Distribution by Type of Software and Therapeutic Area
Table 15.13 Heat Map Representation: Distribution by Type of Software and Area of Application
Table 15.14 BioTel Care: Annual Revenues, 2015-2021 (USD Million)
Table 15.15 Masimo: Annual Revenues, 2015-2021 (USD Million)
Table 15.16 LifeWatch: Annual Revenues, 2015-2021 (USD Million)
Table 15.17 Siemens Healthineers: Annual Revenues, 2015-2021 (USD Million)
Table 15.18 Transtek Medical: Annual Revenues, 2015-2021 (USD Million)
Table 15.19 Partnerships and Collaborations: Distribution by Year of Partnership
Table 15.20 Partnerships and Collaborations: Distribution by Type of Partnership
Table 15.21 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 15.22 Partnerships and Collaborations: Distribution by Type of Partnership and Company Size
Table 15.23 Partnerships and Collaborations: Distribution by Type of Software
Table 15.24 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Software
Table 15.25 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Software
Table 15.26 Most Active Players: Distribution by Number of Partnerships
Table 15.27 Partnerships and Collaborations: Regional Distribution
Table 15.28 Partnerships and Collaborations: Country-wise Distribution
Table 15.29 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 15.30 Funding and Investment Analysis: Distribution by Cumulative Year-wise Trend, 2015 - 2021
Table 15.31 Funding and Investment Analysis: Distribution by Amount Invested (USD Million)
Table 15.32 Funding and Investment Analysis: Distribution by Type of Funding
Table 15.33 Funding and Investment Analysis: Distribution by Type of Venture Capital Round
Table 15.34 Funding and Investment Analysis: Distribution by Year and Type of Funding
Table 15.35 Funding and Investment Analysis: Distribution by Type of Funding and Amount Invested (USD Million)
Table 15.36 Funding and Investment Analysis: Distribution by Type of Investor
Table 15.37 Funding and Investment Analysis: Distribution by Type of Software
Table 15.38 Funding and Investment Analysis: Distribution by Type of Software and Amount Invested (USD Million)
Table 15.39 Funding and Investment Analysis: Distribution by Focus Area
Table 15.40 Funding and Investment Analysis: Distribution by Geography
Table 15.41 Funding and Investment Analysis: Distribution by Amount Invested (USD Million) and Region
Table 15.42 Most Active Players: Distribution by Number of Instances
Table 15.43 Most Active Players: Distribution by Amount Invested (USD Million)
Table 15.44 Most Active Investors: Distribution by Number of Instances
Table 15.45 Funding and Investment Analysis: Distribution by Year, Amount Invested and Type of Investor
Table 15.46 Overall Cost Saving Potential of Using Remote Patient Monitoring Solutions, 2021-2030 (USD Million)
Table 15.47 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in North America, 2021-2030 (USD Million)
Table 15.48 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in Europe, 2021-2030 (USD Million)
Table 15.49 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in Asia-Pacific, 2021-2030 (USD Million)
Table 15.50 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in RoW, 2021-2030 (USD Million)
Table 15.51 Global Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market, 2021-2030 (USD Million)
Table 15.52 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Type of Area of Application, 2021 and 2030
Table 15.53 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Blood Glucose, 2021-2030 (USD Million)
Table 15.54 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Blood Pressure, 2021-2030 (USD Million)
Table 15.55 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Blood Temperature, 2021-2030 (USD Million)
Table 15.56 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for ECG, 2021-2030 (USD Million)
Table 15.57 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Oxygen Saturation, 2021-2030 (USD Million)
Table 15.58 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Respiration Rate, 2021-2030 (USD Million)
Table 15.59 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Other Areas of Application, 2021-2030 (USD Million)
Table 15.60 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Therapeutic Area, 2021 and 2030
Table 15.61 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Cardiovascular Disorders, 2021-2030 (USD Million)
Table 15.62 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Infectious Diseases, 2021-2030 (USD Million)
Table 15.63 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Metabolic Disorders, 2021-2030 (USD Million)
Table 15.64 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Oncological Disorders, 2021-2030 (USD Million)
Table 15.65 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Respiratory Disorders, 2021-2030 (USD Million)
Table 15.66 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Other Therapeutic Areas, 2021-2030 (USD Million)
Table 15.67 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Purpose of Software, 2021 and 2030
Table 15.68 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Clinical Purpose, 2021-2030 (USD Million)
Table 15.69 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Commercial Purposes, 2021-2030 (USD Million)
Table 15.70 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Type of Business Model, 2021 and 2030
Table 15.71 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for B2B, 2021-2030 (USD Million)
Table 15.72 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for B2C, 2021-2030 (USD Million)
Table 15.73 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Geography, 2021 and 2030
Table 15.74 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market in North America, 2021-2030 (USD Million)
Table 15.75 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market in Europe, 2021-2030 (USD Million)
Table 15.76 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market in Asia-Pacific, 2021-2030 (USD Million)
Table 15.77 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market in MENA, 2021-2030 (USD Million)
Table 15.78 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market in Latin America, 2021-2030 (USD Million)
Table 15.79 Telemedicine in Remote Patient Monitoring Market, 2021-2030: COVID-19 Impact Scenario (USD Million)

List Of Companies

The following companies and organizations have been mentioned in the report.

  1. 100Plus
  2. 1812 Ventures
  3. 19Labs
  4. 3M Ventures
  5. 3one4 Capital
  6. 42Gears Mobility Systems
  7. 500 Startups
  8. A&D Medical
  9. Abbott
  10. Acceleration Fund
  11. AccessibleRPM
  12. Acetiam
  13. Adelie
  14. AdvaMed Accel
  15. Aerotel Medical Systems
  16. Agatsa Software
  17. AGNITY Healthcare
  18. Ai Health Highway
  19. AloT Health
  20. AliveCor
  21. Aloe Care Health
  22. Alpana Ventures
  23. AltumView Systems
  24. Amadeus Capital Partners
  25. AMC Health
  26. American Heart Association (AHA)
  27. AMN Healthcare
  28. Amwell
  29. Anathem Ventures
  30. Anelto
  31. Anges Québec
  32. Anthem Capital
  33. Aperture Venture Partners
  34. Aphelion Capital
  35. Archimedia
  36. ARTIS Ventures
  37. Asahi Intecc
  38. Ascension Ventures
  39. Ascent Biomedical Ventures
  40. Ascom
  41. AstraZeneca
  42. athenahealth
  43. Atlantic Bridge
  44. Audicor Cardiometrics
  45. Aurora Health Care
  46. Aviva Ventures
  47. AVS Medical
  48. Axilor
  49. Babylon Health
  50. Babyscripts
  51. Bank of the Philippine Islands (BPI)
  52. Bardy Diagnostics
  53. Baxter Ventures
  54. Bayer
  55. BDC Capital
  56. BeatO
  57. Ben Franklin Technology Partners
  58. BettrLife
  59. Bill & Melinda Gates Foundation
  60. BioAdvance
  61. Biobeat
  62. Biofourmis
  63. BioIntelliSense
  64. BioNTech
  65. BioSerenity
  66. Biotechnology Industry Research Assistance Council
  67. BioTel Care
  68. BioTelemetry
  69. Biotricity
  70. Bizmatics
  71. Black Pearl Global Investments
  72. Blue Cross Blue Shield
  73. Blue Spark Technologies
  74. Blume Ventures
  75. BNP Paribas Développement
  76. Bold Capital Partners
  77. Bonfire Ventures
  78. Boston Scientific
  79. Bpifrance
  80. Brainpan Innovations
  81. Braster
  82. Bristol Myers Squibb
  83. Cambia Health Solutions
  84. Canaan Partners
  85. Capital Factory
  86. Capsule Technologies
  87. CAPTUREPROOF
  88. Cardinal Health
  89. Cardiomo
  90. Cardiotrack
  91. Cardiovascular Systems
  92. Care Innovations
  93. CareClix
  94. Caregility
  95. Carematix
  96. CareMonitor
  97. CarePICS
  98. CareSignal
  99. CareSimple
  100. Catex Health
  101. Cathexis Ventures
  102. Centre for Development of Advanced Computing (C-DAC)
  103. Cerner
  104. Certintell
  105. CG Health Ventures
  106. ChartSpan
  107. Chiron Health
  108. ChronicWatch
  109. ChroniSense Medical
  110. Claris Healthcare
  111. Cloud DX
  112. Cohero Health
  113. Comarch 
  114. Compass Medical
  115. Contact Doctor Healthcare
  116. Cover2protect
  117. Cultivation Capital
  118. Curatess
  119. Curatio
  120. Current Health
  121. Daher Capital
  122. DarioHealth
  123. Dassault Systèmes
  124. DaytoDay Health (DTDHI)
  125. DCM Ventures
  126. Delphi Ventures
  127. Department of Science and Technology
  128. Device Authority
  129. Dexcom
  130. Diagnext
  131. Digital Technology Supercluster
  132. Digitalis Ventures
  133. DigiTx Partners
  134. Diversified Healthcare Partners
  135. Doccla
  136. DocEngage
  137. Doconvid AI
  138. Dozee
  139. Dräger 
  140. Dreamit Ventures
  141. Drimpy
  142. DVI Equity Partners
  143. EDBI
  144. Edison Partners
  145. Eko
  146. Elements Health Ventures
  147. Endeavour Vision
  148. Enterprise Ireland
  149. Envolve People Care
  150. eVisit
  151. Eurazeo
  152. FedDev Ontario
  153. FirstLight Home Care
  154. Floodgate
  155. Forefront Analytics
  156. Fosun Pharma
  157. FOUNDER.org
  158. Founders Fund
  159. Foundry
  160. Francisco Partners
  161. Fresenius Medical Care North America
  162. Froedtert & the Medical College of Wisconsin 
  163. Frontline Strategy
  164. Frontline Ventures
  165. FundersClub
  166. Fuse Medical
  167. Gallagher Home Health Services
  168. GatewayMD
  169. Georgian Partners
  170. Gilde Healthcare
  171. GIS Strategic Ventures
  172. Global Telehealth Services
  173. Glooko
  174. Grapheal
  175. Grazia Equity
  176. Great Lakes NeuroTechnologies
  177. Greenspring Associates
  178. Grove Ventures
  179. GrowAyu Technologies
  180. GYANT
  181. Hale Health
  182. HAT Technologies
  183. Health Catalyst Capital
  184. H-Connect
  185. Health Enterprise Partners
  186. Health Recovery Solutions (HRS)
  187. Health Sensei
  188. HealthArc 
  189. HealthCare Ventures
  190. Healthcom
  191. HealthKOS
  192. HealthQuest 
  193. HealthX Ventures
  194. HealthyGx
  195. Heitkamp & Thumann
  196. Henry Schein
  197. Hicuity Health
  198. Highland Capital Partners
  199. Higi
  200. Hikma Ventures
  201. Hitachi Ventures
  202. HNC Virtual Solutions
  203. Hoy Health
  204. Huma
  205. HumanITcare
  206. ICON
  207. iHealth Labs
  208. iHealthHome
  209. Implicity
  210. Indian Angel Network (IAN)
  211. Info360degree
  212. Inhealthcare
  213. Inkblot Labs
  214. Innovaccer
  215. Inova Health System
  216. Insight Partners
  217. INSUD PHARMA 
  218. Insulet
  219. InteliChart
  220. Intermountain Ventures
  221. Invest Partners
  222. IOTA Informatics
  223. IP Group
  224. IPF Partners
  225. IQ Capital
  226. iRhythm Technologies
  227. Isansys Lifecare
  228. Itochu
  229. Jianke
  230. JNC Medical
  231. Johnson & Johnson
  232. Kaiser Permanente
  233. Karantis360
  234. Kayan Health
  235. Keva Health
  236. Khosla Ventures
  237. KickstartFund
  238. Kinled Holding
  239. Koninklijke Philips
  240. Kratin
  241. Kurma Partners
  242. LabCorp
  243. Laboratory Silicon Valley
  244. Lacuna Health
  245. LBO France
  246. LeewayHertz
  247. Legal & General
  248. Leo Capital
  249. Lifelight
  250. LifeWatch
  251. LionBird
  252. LLR Partners
  253. LRVHealth
  254. LSP
  255. Lumeon
  256. Lumira Ventures
  257. m.Care
  258. m.Doc Smart Clinic
  259. Manchester Capital Management
  260. Manorama Infosolutions
  261. Maple
  262. Martin Ventures
  263. Masimo
  264. MassChallenge
  265. MassMutual Ventures
  266. MAXIS Global Benefits Network
  267. Mayo Clinic
  268. MedAxiom
  269. Medically Home
  270. MediOrbis
  271. MedIoTek Health Systems
  272. MedM
  273. MedTech Innovator
  274. MEDTEQ+
  275. Medtronic
  276. Merisis VP
  277. MicroPort CRM
  278. Mindray Medical International
  279. MMC Ventures
  280. MobileHelp
  281. Moderna
  282. Mor Provident Fund
  283. Mosio
  284. mTelehealth
  285. MTIP
  286. Murata Vios
  287. MVM Life Science Partners
  288. MyVitalz
  289. Nanowear
  290. Nantahala Capital Management
  291. National Institute for Health Research (NIHR)
  292. National Research Council Canada 
  293. National Science Foundation (NSF)
  294. NemoCare Wellness
  295. NeuralRays AI
  296. New Enterprise Associates
  297. Newark Venture Partners
  298. NewYork-Presbyterian Hospital
  299. NGen
  300. NHSX
  301. Nihon Kohden
  302. Northampton General Hospital Trust
  303. Northpond Ventures
  304. Northwell Health
  305. Norwich Ventures
  306. Novo Nordisk
  307. NTTVC
  308. NueCura Partners
  309. NWS Holdings
  310. NXgenPort
  311. OBS Medical
  312. ODDO BHF Private Equity
  313. Olipan Investments
  314. Olive Tree Ventures
  315. Omada Health
  316. OMRON Healthcare
  317. Openspace Ventures
  318. OpenTeleHealth
  319. OpenView Venture Partners
  320. Optimize Health
  321. Optum Ventures
  322. Orb Health
  323. OrbiMed Advisors
  324. Orbita
  325. Orios Venture Partners
  326. OSF HealthCare
  327. Oxehealth
  328. Oxford Finance
  329. Oxford Sciences Innovation
  330. Oxitone Medical
  331. P5 Health Ventures
  332. Par Equity
  333. Paris Saclay Seed Fund
  334. PatientLink
  335. Peerbridge Health
  336. Perceptive Advisors
  337. Peter Thiel's Founders Fund
  338. Pfizer
  339. Pfizer Healthcare Hub
  340. PharmEasy
  341. PHC Holdings
  342. Philips
  343. Phoenix Insurance
  344. PhysIQ
  345. Ping An Insurance
  346. Plug and Play 
  347. Podimetrics
  348. Polaris Partners
  349. Prairie Crest Capital
  350. Prime Venture Partners
  351. Promantra Synergy Solutions
  352. Psagot Investment House
  353. PSIM
  354. PurpleRibbon Healthcare Services
  355. Qardio
  356. Qualcomm Life
  357. Qualcomm Ventures
  358. Questa Capital
  359. Qumra Capital
  360. Qure Ventures
  361. RED Medical Systems
  362. Redox
  363. Reliq Health Technologies
  364. Remote Care Partners
  365. Resideo Life Care Solutions
  366. ResMed
  367. Rex Health Ventures
  368. Rimidi
  369. Rinicare
  370. River Cities 
  371. Roche
  372. Rock Health
  373. Rockstart 
  374. RPM in a Box
  375. RTP Ventures
  376. SaaS Capital
  377. Samsung
  378. Samsung NEXT 
  379. Sanford Health
  380. Scientific Health Development
  381. Scottish Investment Bank
  382. SeamlessMD
  383. Section 32
  384. Senseonics
  385. Sensogram Technologies
  386. Sensome
  387. Sequoia Capital
  388. Seraph
  389. SGInnovate
  390. Shea Ventures
  391. Shenzhen Capital
  392. Siemens Healthineers
  393. Silicon Valley Bank
  394. Sinopharm
  395. Sinovac Biotech
  396. Siren
  397. Smith+Nephew
  398. Smiths Medical
  399. Social Capital
  400. SoftBank Vision Fund
  401. Soleus Capital 
  402. Somatix
  403. Sony Innovation Fund
  404. SOSV
  405. Spacelabs Healthcare
  406. Spectrum Health
  407. Spry
  408. Square 1 Bank
  409. St. Luke’s Medical Center
  410. StartX
  411. StartUp Health
  412. Stasis Labs
  413. Strados Labs
  414. SV Health Investors
  415. Swanhill Capital
  416. TaiDoc Technology
  417. Technology Development Board (TDB)
  418. techstars 
  419. Teladoc Health
  420. TeleMedCare
  421. Teslon Technologies
  422. Three Leaf Ventures
  423. TiaTech Health Technologies 
  424. Tiger Global Management
  425. TogetherMD
  426. Torrey Pines
  427. TouchPointCare
  428. Transtek
  429. Trapollo
  430. TYLT Ventures
  431. TytoCare
  432. U.S. Army Medical Research and Development Command (USAMRDC)
  433. Unilever Ventures
  434. Union Chimique Belge
  435. UnitedHealth
  436. University Growth Fund
  437. University of Colorado
  438. Updata Partners
  439. UPMC

PRICING DETAILS

USD 5,899

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com